INNSBRUCK, AUSTRIA — Cardiometabolic benefits from bariatric surgery in the obese stem more from its favorable lipoprotein-profile "remodeling" effects, in particular to variable changes in HDL subtypes, than on improvements in overall HDL or LDL levels the way they are usually measured in clinical practice, suggested several reports from the European Atherosclerosis Society 2016 Congress.
Although levels of total cholesterol, LDL cholesterol, and triglycerides dropped significantly from baseline to 6 months after Roux-en-Y gastric-bypass surgery, total HDL-cholesterol levels did not change, in a prospective study of 94 patients presented by Dr Gersina Rega-Kaun (Medical University of Vienna, Austria).
The reduction in triglycerides, however, was correlated with a shuffling of HDL-particle subtypes after surgery, such that over 6 months, mean levels of "small, dense" HDL fell from 10 mg/dL to 6 mg/dL (P<0.001) while those of "large, buoyant" HDL rose from 11 mg/dL to 15 mg/dL (P<0.001). The increase in large, buoyant HDL was inversely correlated (P<0.05) with the drop in triglycerides, but not with changes in total or LDL cholesterol, Rega-Kaun reported.
Larger HDL species appear more atheroprotective than the apolipoprotein-rich smaller ones, in part through antioxidative properties and stimulation of nitric-oxide synthase, according to Rega-Kaun. Her study, she told heartwire from Medscape, suggests that "the surgery remodels the HDL profile, which leads to better antioxidation and anti-inflammatory function, and this contributes to, for example, improved endothelial function."
In support of those findings, a different group studied 34 obese patients as they followed a prospective plan of diet and lifestyle changes prior to undergoing gastric bypass surgery.
Average weight loss reached 10.5% after the preoperative lifestyle changes and 34.7% 1 year after the surgery, reported investigators led by Dr Christian Abendstein Kjellmo (Nordland Hospital, Bodø, Norway).
After the diet and lifestyle changes, total LDL-cholesterol fell significantly (P<0.0001) as did LDL type 1–2 (large, buoyant) and LDL type 3–7 (small, dense) subfractions (P<0.01). All changes persisted a year after surgery, except for the return to baseline for the LDL type 3–7 subfraction.
With diet and lifestyle intervention, total HDL cholesterol fell slightly but significantly (P<0.01) and apolipoprotein-rich small HDL decreased significantly as well (P<0.0001). But a year after bariatric surgery, total HDL-cholesterol had rebounded to significantly higher than baseline (P<0.0001) accompanied by a significant climb in large HDL (P<0.0001).
Interestingly, at no point in the follow-up—not after lifestyle intervention nor a year after surgery—was a change observed in serum cholesterol efflux capacity (Sigma-Aldrich assay).
The findings show contrasting effects of diet/lifestyle changes and bariatric surgery on lipoprotein levels and function and different effects on markers of cardiometabolic health, perhaps, according to the group, secondary to changes in gut microbiota. In short, they "may in part explain the positive effects of bariatric surgery on cardiovascular morbidity and mortality in morbidly obese patients."
Dr Petia Doytcheva (Center for Molecular Cardiology, Zurich, Switzerland) agreed that the surgery's effects on relative levels of different HDL subtypes and their different functions seem largely behind its observed survival benefits. "Normally, we measure the total value of HDL in serum, but HDL function is more important," she said to heartwire .
It seems to be, she said, that the obese, especially those with diabetes, have a preponderance of small dysfunctional HDL species and therefore impairment of HDL-related reverse cholesterol transport and endothelial function and that those derangements are reversed by bariatric surgery in a way that diet therapy cannot match.
That was the message, she said, from her group's allocation of 62 patients with a body-mass index exceeding 35 kg/m2 to undergo Roux-en-Y gastric bypass or follow a program featuring a hypocaloric weight-reduction diet and lifestyle-modification counseling, all with medical attention for any diabetes, hypertension, dyslipidemia, or other obesity-related complications.
The 32 patients who had surgery lost 25.9 kg over 6 months, compared with 11 kg for the 30 following the diet/lifestyle program (P<0.0001). Total cholesterol, triglycerides, and fasting glucose levels were significantly reduced over the period in both groups, and total HDL cholesterol was significantly increased in both groups. But LDL cholesterol fell significantly only in the group that underwent bariatric surgery.
However, Doytcheva said, levels of small, dense HDL particles were significantly reduced and large, buoyant HDL was significantly raised after 6 months in the bariatric-surgery group but not the diet/lifestyle group, "meaning there was better HDL function after bariatric surgery."
Furthermore, endothelial nitric-oxide production (measured by DAF-2 fluorescence and paraoxonase-1 antioxidant activity) stimulated by smaller HDL subtypes was improved by 40% after 6 months compared with baseline in the bariatric-surgery group, as compared with only 9% in the diet/lifestyle group (P<0.0001).
That is, weight loss from bariatric surgery, but not conventional weight loss, Doytcheva said, "restored endothelium-protective HDL properties" despite improvements in traditional lipid profiles following both weight-loss strategies.
None of the authors from the three reports had relevant financial relationships.
Heartwire from Medscape © 2016
Cite this: HDL Subtypes Help Mediate Bariatric Surgery's Cardiometabolic Benefits - Medscape - Jun 09, 2016.